It is worth noting that the increased prevalence of CKM syndrome during the COVID–19 pandemic may be associated with systemic inflammatory state and metabolic disorders exacerbated by viral infection [56], further highlighting the importance of managing insulin resistance and metabolic health in the context of chronic inflammation. This evidence concerns the gene INS and metabolic disease.